Pharmamark

What Pharmamark does

Pharmamark is a privately held Australian health and wellness company headquartered in Eight Mile Plains, founded in 2016, with a headcount in the 11-50 range. Its firmographic positioning is the provision of nutrition and technology intelligence to the health and wellness sector, and the company operates a B2B go-to-market targeting pharmaceutical firms and research institutions.

The company's technology offering centers on a proprietary multi-agent artificial intelligence platform designed for oncology drug discovery. The platform is described as analyzing large datasets and reviewing thousands of research documents to identify promising drug candidates, with reported capabilities of achieving over 90% accuracy in complex data retrieval, reducing time-to-insights by up to 15-fold, and processing over 4,500 research documents per analysis cycle to identify the ten most viable treatment combinations from more than 8,000 possibilities. The platform is positioned to support R&D across preclinical, clinical, regulatory, and commercial functions, and the stated roadmap extends to hypothesis generation and automated scientific reporting.

Pharmamark's revenue model is not publicly disclosed and no pricing, customer, or contract value data was available. The most recent capital event on record is a AUD 5.5 million funding round in August 2019 from BioScience Managers Limited, and a strategic co-development partnership with Globant was announced on 2026-02-19 to build out the multi-agent AI platform. The company maintains a vertical specialization in oncology, with particular emphasis on marine-derived anti-cancer compounds, which is intended to differentiate it within the broader pharmaceutical analytics landscape.

Name

Pharmamark

Website

https://pharmamark.com.au

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

Pharmamark is an Australian health and wellness firm that operates a multi-agent AI platform for oncology drug discovery, serving pharmaceutical companies and research institutions, with a stated specialization in marine-derived anti-cancer compounds.

Ownership category

akta.pro rank

Product category

Health and Wellness Intelligence

NAICS

Computer Systems Design and Related Services (54151), Software Publishers (51321)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

akta.pro secondary industry

Pharmacovigilance & Drug Safety Software (HLAGAJAK)

Keywords

• Health wellness intelligence
• Nutrition data analytics
• Wellness technology insights
• Health sector intelligence
• Nutrition market research

Headquarters

HQ city

Eight Mile Plains

HQ country

Australia

HQ region

Oceania

Markets served

GTM type

B2B

Offering type

Software

Core offering

Pharmamark provides nutrition and technology intelligence in the health and wellness sectors, supporting pharmaceutical and research organizations with data-driven analytics and AI-enabled research capabilities. The company focuses on delivering technology-enabled intelligence solutions that enhance R&D and decision-making across health, wellness, and pharmaceutical contexts.

Differentiator

Problem solved

Functional benefit

Products and services

• Multi-Agent AI Platform for Oncology Drug Discovery
• Complex Data Retrieval System

Quantifiable outcome

• Achieves over 90% accuracy in complex data retrieval
• +3 more outcomes

Segments1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• GlobantflagshipStrategic or Co-development Partner · 19 February 2026PharmaMar partnered with digital technology firm Globant to launch a multi-agent AI system designed to accelerate cancer drug discovery. The collaboration aims to enhance PharmaMar's R&D capabilities across preclinical, clinical, regulatory, and commercial functions. The collaboration is mutual and co-development in nature, with both companies contributing to the development of the AI platform for oncology research.

Recent moves4 records

Expansion highlights4 records

Direct peers

• Fingerpaint: Fingerpaint is an independent health and wellness marketing agency offering brand strategy, creative, and analytics. Comparable to Pharmamark as a similarly-sized specialist agency serving health/wellness clients with technology-enabled services.
• Real Chemistry: Real Chemistry is a healthcare marketing and data-driven communications firm serving pharma, biotech, and consumer health brands. Comparable to Pharmamark in combining health-sector marketing expertise with proprietary data and AI tooling.
• Indegene: Indegene is a healthcare-focused commercialization and analytics firm combining technology, data, and domain expertise to help life sciences and wellness companies. Comparable to Pharmamark as a vertically-specialized partner delivering technology-enabled intelligence to health and wellness clients.

Regional players

• Slingshot (Australia): Slingshot is an Australian health-focused marketing and communications agency. Comparable to Pharmamark through shared regional footprint and similar target clients in the Australian healthcare and wellness market.
• Ward6: Ward6 is an Australian healthcare creative agency serving pharma and consumer health clients across APAC. Comparable to Pharmamark as an Australia-based regional competitor operating in the same health/wellness communications category.

Broad incumbents

• Havas Health & You: Havas Health & You is the global health and wellness communications network of Havas, offering creative, medical, and data services. Comparable to Pharmamark through overlapping health/wellness marketing and intelligence offerings, but with significantly broader global reach.
• IQVIA: IQVIA is a global leader in healthcare data, analytics, and commercial services for life sciences. Comparable to Pharmamark as a broader incumbent that overlaps in health intelligence and commercial data, but at vastly larger scale across pharma and consumer health.
• Syneos Health Communications: Syneos Health is a biopharmaceutical solutions organization with a dedicated communications arm serving pharma and consumer health clients. Comparable to Pharmamark as a broad incumbent operating across health communications and commercial intelligence.
• Publicis Health: Publicis Health is the healthcare-focused network of Publicis Groupe, providing marketing, communications, and data services to pharma and consumer health brands. Comparable to Pharmamark as a much larger incumbent serving the same end markets.

Emerging players

• Definitive Healthcare: Definitive Healthcare provides commercial intelligence and analytics for the healthcare industry, including life sciences and provider organizations. Comparable to Pharmamark through shared focus on healthcare data-driven insights and decision support for commercial stakeholders.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/pharmamark-nutrition-pty-ltd

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmamark